Euthyroid Sick Syndromes: Clinical Trials

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2
Phase 2	2	Completed 2

Follow Euthyroid Sick Syndromes: new trials by email Literature Review of Euthyroid Sick Syndromes trials Research Report on Euthyroid Sick Syndromes

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Developing Oral LT3 Therapy for Heart Failure - HFpEF liothyronine, Placebo - Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome	Phase 1 / Phase 2	Completed	University of Pennsylvania	28	2020-03-08	2025-01-08
Developing Oral LT3 Therapy for Heart Failure - HFrEF Liothyronine, Placebo - Heart Failure With Reduced Ejection Fraction (HFrEF), Low T3 Syndrome	Phase 1 / Phase 2	Completed	University of Pennsylvania	28	2020-02-11	2024-12-24

Narrower conditions

Heart Failure (2)

Broader conditions

Cardiovascular Diseases (2)  ·  Endocrine System Diseases (2)  ·  Heart Diseases (2)  ·  Thyroid Diseases (2)

Interventions

Triiodothyronine (2)

Sponsors

University of Pennsylvania (2)

Countries

United States (2)

Top investigators

Anne R Cappola, MD,ScM (2)

NIH funding

R61HL146390 (2)